Formulary Drug Review: Edaravone

Formulary Drug Reviews

INDICATIONS AND BACKGROUND Ibuprofen lysine is indicated to close a clinically significant patent ductus arteriosus (PDA) in premature infants weighing between 500 and 1,500 g who are no more than 32 weeks gestational age when usual medical management (fluid restriction, diuretics, respiratory support, etc.) is ineffective. Indomethacin injection is indicated for the treatment of PDA in prematu...

Clinical monograph for drug formulary review: erectile dysfunction agents.

BACKGROUND Significant advances in the pharmacologic treatment of erectile dysfunction (ERD) have occurred in recent years, most notably the introduction of sildenafil, the first oral selective phosphodiesterase type 5 (PDE5) inhibitor, in 1998. Sildenafil quickly gained acceptance by the medical community and the public because of its broad efficacy for different types of ERD and its ease of u...

Drug control and formulary management in Malaysia.

From the year 2000, the national drug expenditure has seen an increase from RM346 million ($91 million) to RM915 million ($241 million) in 2005. From the year 2004 to 2005, an increase of 13.3% was recorded [1]. Factors that may contribute to this increase include increase in drug prices, a growing and aging population, higher expectation of the public regarding equality in assessing therapy, l...

Physicians' liability and drug formulary restrictions.

National Drug Formulary review of statin therapeutic group using the multiattribute scoring tool

PURPOSE HMG-CoA reductase inhibitors (statins) are extensively used in treating hypercholesterolemia. The statins available in Malaysia include atorvastatin, lovastatin, pravastatin, rosuvastatin, simvastatin, and fluvastatin. Over the years, they have accumulated in the National Drug Formulary; hence, the need for review. Effective selection of the best drugs to remain in the formulary can bec...